PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.
about
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study.Ductal adenocarcinoma of the prostate: Clinical and biological profiles.Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.Genomic tests to guide prostate cancer management following diagnosis.PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort.Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort.PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles.Ethnicity and ERG frequency in prostate cancer.Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports.MSH2 Loss in Primary Prostate Cancer.PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer.The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the Literature
P2860
Q36192598-64FB3844-3725-418F-88CE-2D8F8CC55739Q38683009-8DA42C2B-4938-4C9A-BED3-DD4C20879F75Q38967389-AEEB3BBE-AD22-4A39-A91A-BEA61B217EEDQ39170943-57480F39-8E22-4925-B752-6277B6206ADCQ42371556-76507DEE-5F78-4AB4-9DC4-1E67D22DB948Q42845103-A14A6D6C-C795-4358-98E9-5C0EB35F391EQ46000712-34D075D4-3E9D-42F0-876E-B99D227F81C7Q46504038-09E4561A-A030-4A83-AC4B-70D5440669DEQ47094262-1EAF0873-576C-44C3-BA9D-2DA7BFF42AB6Q47976701-FCC2B78A-AC60-4FCA-AF9E-D707295B35AAQ49788391-EA2DF0AA-47BD-43D4-9628-D6C541C24108Q57073785-13810B67-FD8C-443E-B56E-85C7134F4196
P2860
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
PTEN Loss as Determined by Cli ...... e Survival in Prostate Cancer.
@en
PTEN Loss as Determined by Cli ...... e Survival in Prostate Cancer.
@nl
type
label
PTEN Loss as Determined by Cli ...... e Survival in Prostate Cancer.
@en
PTEN Loss as Determined by Cli ...... e Survival in Prostate Cancer.
@nl
prefLabel
PTEN Loss as Determined by Cli ...... e Survival in Prostate Cancer.
@en
PTEN Loss as Determined by Cli ...... e Survival in Prostate Cancer.
@nl
P2093
P2860
P1476
PTEN Loss as Determined by Cli ...... e Survival in Prostate Cancer.
@en
P2093
Antonio Hurtado-Coll
Carlos L Morais
Daniel W Lin
Dean Troyer
Ian M Thompson
James D Brooks
Jeffrey Simko
Jesse K McKenney
Ladan Fazli
Lawrence D True
P2860
P304
P356
10.1016/J.EUF.2015.07.005
P577
2016-06-01T00:00:00Z